Favorable Outcome In Clinically Stage II Melanoma Patients Is Associated With The Presence Of Activated Tumor Infiltrating T-lymphocytes And Preserved MHC Class I Antigen Expression
Inge S. van Houdt, Berbel J.R. Sluijter, Laura M. Moesbergen, Wim M. Vos, Tanja D. de Gruijl, Barbara G. Molenkamp, Alfons J.M. van den Eertwegh, Erik Hooijberg, Paul A.M. van Leeuwen, Chris J.L.M. Meijer, Joost J. Oudejans